ACA Will Survive Repeal Efforts, But As “Health Reform 1.0,” Experts Predict
Executive Summary
Over the next two years, the Affordable Care Act will mainly survive challenges in the courts, Congress and the states, Project HOPE’s Gail Wilensky and Henry Aaron of the Brookings Institution predicted during a policy conference in Washington, D.C. March 8.
You may also be interested in...
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.